T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis

Completed

• Conditions: Leukemia, Lymphocytic, Acute

• Registration Number: NCT01078337
• Lead Sponsor: Stanford University

Brief Summary

To determine if MRD (minimal residual disease) can be found in the blood (only) as opposed to bone marrow in children with ALL (acute lymphoblastic leukemia).

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2002-11
• Primary Completion: 2007-10
• Study Completion: 2007-10
• Status Verified: 2010-02
• Study First Submitted: 2010-02-26
• Study First Submitted QC: 2010-03-01
• Last Update Submitted: 2010-03-01
• Study First Posted: 2010-03-02
• Last Update Posted: 2010-03-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

• Children with newly diagnosed T-cell ALL

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Stanford University School of Medicine; 🇺🇸 Stanford, California, United States